EL-PFDD Meeting
Helping FDA regulators and drug developers understand the needs of the SCN2A community
Externally-led Patient-Focused Drug Development (EL-PFDD) Meetings
FamilieSCN2A Foundation submitted a letter of intent to host an Externally-led Patient-Focused Drug Development (EL-PFDD) meeting with the FDA. The goal of this public meeting is to share the critical patient voice for future drug development efforts. Stay tuned for updates.
Capturing the Patient and Caregiver Voice
The main goal of this event is to capture the patient and caregiver voice. Schedule time with Melody Kisor, Director of Advocacy, to share your story.
Part of the Patient-Centered Drug Development advocacy plan
Patient-Centered Drug Development is an intentional effort to ensure that patient needs and priorities are meaningfully included at all stages of clinical research and development. Regulatory and industry partners play critical roles in the treatment development process. Learn how FamilieSCN2A engages in patient-centered drug development by amplifying the patient voice with regulatory agencies and collaborating with industry partners.
